# A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants

> **NCT07537231** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Postmenopausal Women
- Absorption
- Metabolism
- Excretion

## Interventions

- **DRUG:** [14C]GS1-144

## Key facts

- **NCT ID:** NCT07537231
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-04-09
- **Primary completion:** 2026-04-18
- **Final completion:** 2026-12-31
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537231, "A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07537231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*